The Interface of Therapeutics and Genomics in Cardiovascular Medicine

Pharmacogenomics has a burgeoning role in cardiovascular medicine, from warfarin dosing to antiplatelet choice, with recent developments in sequencing bringing the promise of personalised medicine ever closer to the bedside. Further scientific evidence, real-world clinical trials, and economic model...

Descripción completa

Detalles Bibliográficos
Autores principales: Magavern, E. F., Kaski, J. C., Turner, R. M., Janmohamed, A., Borry, P., Pirmohamed, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Invited Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851637/
https://www.ncbi.nlm.nih.gov/pubmed/33528719
http://dx.doi.org/10.1007/s10557-021-07149-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851637/
https://www.ncbi.nlm.nih.gov/pubmed/33528719
http://dx.doi.org/10.1007/s10557-021-07149-3

Ejemplares similares